Abortion regulation in Europe in the era of COVID-19: a spectrum of policy responses.

Abortion regulation in Europe in the era of COVID-19: a spectrum of policy responses.
复制标题

DOI:
10.1136/bmjsrh-2020-200724
复制
发表时间:
2021-10
影响因子:
3.3
通讯作者:
Gemzell-Danielsson K
Gemzell-Danielsson K
中科院分区:
医学3区
文献类型:
--
作者:
Moreau C;Shankar M;Glasier A;Cameron S;Gemzell-Danielsson K

文献摘要

参考文献

被引文献

相似文献

在欧洲疫情期间,前所未有的公共卫生行动限制了行动和非COVID相关的卫生服务,可能影响了堕胎护理。在缺乏确保获得这一基本卫生服务的共同办法的情况下,我们试图描述欧洲疫情期间堕胎政策的变化,以确定在公共卫生危机期间改善堕胎服务的提供和获得的战略。我们从46个国家/地区收集了信息:国家专家对其中31个国家/地区完成了调查,我们对其中15个国家/地区进行了案头审查。我们描述了堕胎法规以及大流行期间法规和实践的变化。在COVID-19期间,六个国家禁止堕胎,一个国家暂停堕胎。在12个国家/地区,由于COVID-19,手术流产的机会减少,而在11个国家/地区,患有COVID-19症状的妇女无法获得或延迟获得服务。没有一个国家扩大了堕胎的妊娠限制。COVID-19期间的变化主要是为了减少面对面咨询,发生在13个国家/地区。共有8个国家/地区提供9周以上的米非司酮和米索前列醇家庭药物流产(从9周+6天到11周+6天),13个国家/地区提供最长9周的药物流产(在某些情况下,只能在家里服用米索前列醇)。只有六个国家/区域提供远程医疗堕胎服务。对COVID-19限制缺乏统一的政策回应,扩大了欧洲堕胎机会的不平等,但疫情期间部署的一些创新,包括远程医疗,可以作为确保堕胎护理连续性和公平性的催化剂。
Unprecedented public health actions restricting movement and non-COVID related health services are likely to have affected abortion care during the pandemic in Europe. In the absence of a common approach to ensure access to this essential health service, we sought to describe the variability of abortion policies during the outbreak in Europe in order to identify strategies that improve availability and access to abortion in times of public health crises. We collected information from 46 countries/regions: 31 for which country-experts completed a survey and 15 for which we conducted a desk review. We describe abortion regulations and changes to regulations and practice during the pandemic. During COVID-19, abortions were banned in six countries and suspended in one. Surgical abortion was less available due to COVID-19 in 12 countries/regions and services were not available or delayed for women with COVID-19 symptoms in eleven. No country expanded its gestational limit for abortion. Changes during COVID-19, mostly designed to reduce in-person consultations, occurred in 13 countries/regions. Altogether eight countries/regions provided home medical abortion with mifepristone and misoprostol beyond 9 weeks (from 9 weeks+6 days to 11 weeks+6 days) and 13 countries/regions up to 9 weeks (in some instances only misoprostol could be taken at home). Only six countries/regions offered abortion by telemedicine. The lack of a unified policy response to COVID-19 restrictions has widened inequities in abortion access in Europe, but some innovations including telemedicine deployed during the outbreak could serve as a catalyst to ensure continuity and equity of abortion care.
DOI: 10.1016/s2214-109x(14)70227-x
发表时间: 2014-06-01
影响因子: 34.3
作者:
Say, Lale;Chou, Doris;Alkema, Leontine
通讯作者: Alkema, Leontine
DOI: 10.1111/1471-0528.13552
发表时间: 2016-08-01
影响因子: 5.8
作者:
Singh, S.;Maddow-Zimet, I.
通讯作者: Maddow-Zimet, I.
DOI: 10.1016/j.contraception.2016.06.019
发表时间: 2016-11-01
期刊: CONTRACEPTION
影响因子: 2.9
作者:
Grossman, Daniel;Grindlay, Kate;Burns, Bridgit
通讯作者: Burns, Bridgit
DOI: 10.1080/26410397.2020.1758394
发表时间: 2020-12
影响因子: 6
作者:
Todd-Gher J;Shah PK
通讯作者: Shah PK
DOI: 10.1093/humrep/dex071
发表时间: 2017-06-01
期刊: HUMAN REPRODUCTION
影响因子: 6.1
作者:
Cameron, S.;Glasier, A.;Volpe, A.
通讯作者: Volpe, A.